Cure Rare Disease receives funding for SCA3 gene therapy trial
On February 6th, the US not-for-profit biotechnology company Cure Rare Disease announced that they have been awarded 5.69 million dollars in funding from the Californian Institute of Regenerative Medicine (CIRM) […]
Cure Rare Disease receives funding for SCA3 gene therapy trial Read More »